Skip to main content
. 2015 Jun 19;15:53. doi: 10.1186/s12894-015-0040-7

Fig. 2.

Fig. 2

Kaplan–Meier survival analysis in patients positive and negative for DYRK2 expression. Differences in disease-specific survival between subgroups were analyzed by log-rank test. Disease-specific survival was significantly longer for DYRK2-positive patients than for DYRK2-negative patients (P = 0.017)